These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1502478)

  • 21. Cisapride for gastro-oesophageal reflux and peptic oesophagitis.
    Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S
    Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisapride for gastroesophageal reflux disease: a placebo-controlled, double-blind study.
    Richter JE; Long JF
    Am J Gastroenterol; 1995 Mar; 90(3):423-30. PubMed ID: 7872282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for relapse and maintenance treatment with cisapride in gastro-oesophageal reflux disease.
    Tytgat GN; Blum AL; Verlinden M
    Aliment Pharmacol Ther; 1995 Jun; 9(3):271-80. PubMed ID: 7654889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis.
    Pouderoux P; Kahrilas PJ
    Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Conservative therapy of reflux esophagitis].
    Koop H
    Z Gastroenterol Verh; 1990 Apr; 25():135-7. PubMed ID: 1694350
    [No Abstract]   [Full Text] [Related]  

  • 26. Heartburn treatment in primary care: randomised, double blind study for 8 weeks.
    Hatlebakk JG; Hyggen A; Madsen PH; Walle PO; Schulz T; Mowinckel P; Bernklev T; Berstad A
    BMJ; 1999 Aug; 319(7209):550-3. PubMed ID: 10463897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology and treatment of gastro-oesophageal reflux disease.
    Vantrappen G; Janssens J
    Scand J Gastroenterol Suppl; 1989; 165():7-12; discussion 27-8. PubMed ID: 2574907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis--results from the maintenance phase of the EXPO study.
    Labenz J; Armstrong D; Zetterstrand S; Eklund S; Leodolter A
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1165-71. PubMed ID: 19298581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two different dose regimens of cisapride in the treatment of reflux oesophagitis: a double-blind comparison with ranitidine.
    Geldof H; Hazelhoff B; Otten MH
    Aliment Pharmacol Ther; 1993 Aug; 7(4):409-15. PubMed ID: 8218755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
    Boccia G; Manguso F; Miele E; Buonavolontà R; Staiano A
    Am J Gastroenterol; 2007 Jun; 102(6):1291-7. PubMed ID: 17319927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cisapride versus ranitidine in reflux esophagitis].
    Janisch HD
    Z Gastroenterol; 1990 Apr; 28 Suppl 1():67-9; discussion 77-8. PubMed ID: 2192508
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of cisapride on food-stimulated gastro-oesophageal reflux: a radiological study.
    Gelineck J; Aksglade K; Funch-Jensen P; Thommesen P
    Rontgenblatter; 1990 Aug; 43(8):352-4. PubMed ID: 2204995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
    Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
    Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis.
    Galmiche JP; Fraitag B; Filoche B; Evreux M; Vitaux J; Zeitoun P; Fournet J; Soule JC
    Dig Dis Sci; 1990 May; 35(5):649-55. PubMed ID: 2331957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice.
    Dakkak M; Jones BP; Scott MG; Tooley PJ; Bennett JR
    Br J Clin Pract; 1994; 48(1):10-4. PubMed ID: 8179973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omeprazole. A review of its use in Helicobacter pylori infection, gastro-oesophageal reflux disease and peptic ulcers induced by nonsteroidal anti-inflammatory drugs.
    Langtry HD; Wilde MI
    Drugs; 1998 Sep; 56(3):447-86. PubMed ID: 9777317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of acid reflux inhibition by drug therapy in reflux esophagitis.
    Sekiguchi T; Nishioka T; Matsuzaki T; Sugiyama M; Kusano M; Horikoshi T; Toki M; Ohwada T; Kobayashi S
    Gastroenterol Jpn; 1991 Apr; 26(2):137-44. PubMed ID: 2040397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical use of cisapride in gastro-oesophageal reflux disease, with particular focus on the long-term treatment aspects.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 211():39-43. PubMed ID: 8545630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.